Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
HealthCare Royalty Partners
company
About
HealthCare Royalty Partners is a global investment firm that partners with healthcare companies, non-profit institutions and inventors.
- 11 - 50
Highlights
Details
- Industries
- Asset Management,Biotechnology,Financial Services,Medical Device,Pharmaceutical
- Founded date
- Jan 1, 2007
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Investor Type
- PE
We are a $3.0+ billion global healthcare investment firm. We invest primarily in commercial stage healthcare product assets that have significant clinical value, strong barriers to entry and that are marketed by some of the world’s largest pharmaceutical companies. Over the past decade, our senior investment team has completed more than 60 royalty investments valued in excess of $2.5 billion. For more information, visit www.healthcareroyalty.com.
Investments
Number of Investments
Number of Lead Investments
3
2
HealthCare Royalty Partners has made 3 investments. Their most recent investment was on
Jun 30, 2022, when Ardelyx raised $20M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jun 30, 2022
Ardelyx
|
Post-IPO Debt | $20M | Biotechnology | Yes |
|
Feb 12, 2014
Nuron Biotech
|
Private Equity（PE） | $22.70M | Biotechnology | — |
|
Dec 26, 2012
Nuron Biotech
|
Private Equity（PE） | $80M | Biotechnology | Yes |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
